Haemonetics Corp (HAE)

Cost of Revenue

$576.17M

TTM · Period ending: · USD

HAE logo

HAE Cost of Revenue

Latest reported$576.17M
HAE TTM Cost of Revenue ($57.80M → $576.17M)
High-resolution chart · PNG

HAE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Haemonetics Corp Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
576,171,000
569,129,000
569,665,000
570,731,000
581,146,000
608,493,000
614,164,000
616,855,000
610,161,000
597,140,000
582,959,000
578,284,000
570,247,000
545,787,000
516,465,000
491,213,000
468,781,000
467,570,000
470,546,000
469,318,000
456,150,000
443,004,000
451,255,000
462,010,000
483,315,000
500,657,000
516,672,000
521,935,000
526,326,000
550,043,000
541,124,000
527,691,000
518,832,000
492,015,000
508,804,000
512,818,000
508,008,000
507,622,000
505,986,000
503,753,000
502,144,000
494,118,000
467,912,000
463,549,000
468,619,000
475,955,000
483,492,000
483,817,000
480,222,000
470,143,000
471,295,000
485,084,000
485,629,000
463,860,000
429,117,000
390,066,000
363,146,000
358,605,000
349,078,000
337,148,000
326,730,000
321,485,000
319,933,000
316,356,000
313,381,000
307,949,000
297,218,000
294,647,000
289,774,000
289,709,000
288,414,000
279,292,000
269,352,000
258,715,000
248,333,000
237,412,000
229,448,000
222,307,000
215,553,000
208,453,000
203,850,000
199,198,000
193,909,000
190,218,000
186,869,000
185,722,000
188,873,000
190,180,000
190,914,000
192,109,000
187,092,000
185,642,000
187,669,000
182,260,000
179,163,000
176,165,000
168,933,000
165,143,000
158,167,000
145,860,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.